Clinical Trial

Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Despite Transcatheter aortic valve implantation (TAVI) evolution regarding techniques, equipment and experience, the need for permanent pacemaker implantation (PPI) post-TAVI remains an important drawback. The electrophysiology testing to stratify the risk or necessity of PPI post-TAVI is endorsed by the up-to-date guidelines and consensus documents and it is a valuable cut-off based method. Part of the answer is maybe hidden in the easy and applicable testing of the atrioventricular conduction system through rapid atrial pacing (RAP) with a common temporary pacemaker lead. This trial is designed to investigate the role and value of RAP after TAVI as a predictor of the necessity of new PPI.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-01-02; most recent amendment 2024-12-09.
Status change: Not Yet Recruiting → Recruiting 2024-04-12
Trial Details
NCT Number NCT06189976
Lead Sponsor National and Kapodistrian University of Athens
Collaborators: Centre Hospitalier Universitaire Saint Pierre
Conditions Aortic Valve Disease, Transcatheter Aortic Valve Implantation, TAVI
Enrollment 400 participants
Start Date 2024-03-01
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-12